Modulation of Microenvironment Acidity Reverses Anergy in Human and Murine Tumor-Infiltrating T Lymphocytes
Published version of a preprint
The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
Stimulating the effector functions of tumor-infiltrating T lymphocytes (TIL) in primary and metastatic tumors could improve active and adoptive T-cell therapies for cancer. Abnormal glycolysis, high lactic acid production, proton accumulation, and a reversed intra–extracellular pH gradient are thought to help render tumor microenvironments hostile to roving immune cells. However, there is little knowledge about how acidic microenvironments affect T-cell immunity. Here, we report that lowering the environmental pH to values that characterize tumor masses (pH 6–6.5) was sufficient to establish an anergic state in human and mouse tumor-specific CD8+ T lymphocytes. This state was characterized by impairment of cytolytic activity and cytokine secretion, reduced expression of IL-2Rα (CD25) and T-cell receptors (TCR), and diminished activation of STAT5 and extracellular signal–regulated kinase (ERK) after TCR activation. In contrast, buffering pH at physiologic values completely restored all these metrics of T-cell function. Systemic treatment of B16-OVA–bearing mice with proton pump inhibitors (PPI) significantly increased the therapeutic efficacy of both active and adoptive immunotherapy. Our findings show that acidification of the tumor microenvironment acts as mechanism of immune escape. Furthermore, they illustrate the potential of PPIs to safely correct T-cell dysfunction and improve the efficacy of T-cell–based cancer treatments. Cancer Res; 72(11); 2746–56. ©2012 AACR.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Notably, in one study, a pH of 6.5 was found to reversibly impair T cell function, characterized by a reduced expression of T cell receptor components in melanoma patients.307”
From Drug repurposing for cancer therapy (2024) · cites this paper as [307]
In the citing paper
“Cancer cells compete with immune cells for glucose uptake (by SLC2A1/GLUT1), produce lactic acid (by LDHA), and generate an acidic extracellular milieu (through the activity of CA9), all of which are immunosuppressive (77–86).”
From HIF inhibitor 32-134D eradicates murine hepatocellular carcinoma in combination with anti-PD1 therapy (2022) · cites this paper as [78]
In the citing paper
“Thus, a metabolic switch towards less hypoxic and more oxidative metabolism that favors CD8+ T-cell effector function (62) might have facilitated the enhanced CD8+ T cell effector function with ExTr.”
Citations
Cites
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Why Do Cancers Have High Aerobic Glycolysis?
Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784 · cited 4×
“and increased glucose consumption (7).”
BackgroundInfluentialRegulation of cancer cell metabolism
Cairns, R. A., Harris, I. S., & Mak, T. W. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2981 · Cited by 4,744
Carbonic anhydrases: novel therapeutic applications for inhibitors and activators
Supuran, C. T. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2467 · Cited by 3,192 · cited 1×
“In addition, excessive CO2 release caused by altered glycolysis leads to increased tumor expression of carbonic anhydrase IX (CA-IX), thus contributing to further acidification of the extracellular tumor environment (8, 9).”
BackgroundT cell receptor antagonist peptides induce positive selection
Hogquist, K. A., Jameson, S. C., Heath, W. R., Howard, J. L., Bevan, M. J., & Carbone, F. R. (1994) · Cell · doi:10.1016/0092-8674(94)90169-4 · Cited by 2,858
Deaglio, S., Dwyer, K. M., Gao, W., Friedman, D., Usheva, A., Erat, A., Chen, J.-F., Enjyoji, K., Linden, J., Oukka, M., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062512 · Cited by 2,470 · cited 1×
“additional hypoxia-driven metabolic dysfunctions, causing extracellular adenosine accumulation (37), could act in synergy with acidic pH in dampening T-cell function through A2A adenosine receptor–driven cyclic AMP intracellular generation (38).”
BackgroundInhibitory effect of tumor cell-derived lactic acid on human T cells
Fischer, K., Hoffmann, P., Voelkl, S., Meidenbauer, N., Ammer, J., Edinger, M., Gottfried, E., Schwarz, S., Rothe, G., Hoves, S., et al. (2007) · Blood · doi:10.1182/blood-2006-07-035972 · Cited by 1,946 · cited 1×
“Previous reports have shown that the hypoxic and/or metabolic pathways in cancer cells may contribute to tumor immune escape by rendering the tumor microenvironment hostile for normal cells (46, 47).”
BackgroundImmunosuppressive Strategies that are Mediated by Tumor Cells
Rabinovich, G. A., Gabrilovich, D., & Sotomayor, E. M. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141609 · Cited by 1,702 · cited 1×
“Thus, acidity might indeed contribute to the dysfunction of tumor T-cell immunity observed in both mice and humans (31).”
BackgroundHelmlinger, G., Yuan, F., Dellian, M., & Jain, R. K. (1997) · Nature Medicine · doi:10.1038/nm0297-177 · Cited by 1,628 · cited 10×
“Cancer Res; 72(11) June 1, 2012 Cancer Research OF6”
BackgroundInfluentialAltered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer
Nagaraj, S., Gupta, K., Pisarev, V., Kinarsky, L., Sherman, S., Kang, L., Herber, D. L., Schneck, J., & Gabrilovich, D. I. (2007) · Nature Medicine · doi:10.1038/nm1609 · Cited by 1,174 · cited 1×
“peptide complex level (44, 45), thus strengthening T-cell/ target interaction and improving tumor recognition and killing.”
Background
Cited by
LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells
Brand, A., Singer, K., Koehl, G. E., Kolitzus, M., Schoenhammer, G., Thiel, A., Matos, C., Bruss, C., Klobuch, S., Peter, K., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.08.011 · Cited by 2,039
“Accordingly, blocking acidification prior to immunotherapy improved the anti-tumor response (Calcinotto et al., 2012; Pilon-Thomas et al., 2016).”
BackgroundAntiangiogenesis Strategies Revisited: From Starving Tumors to Alleviating Hypoxia
Jain, R. K. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.10.006 · Cited by 1,589
“…factor b [TGF-b] and VEGF) induced by hypoxia or acidosis suppress the activity of T lymphocytes and inhibit the ability of dendritic cells to process tumor antigens and present them to lymphocytes (Barsoum et al., 2014; Calcinotto et al., 2012; Gabrilovich et al., 2012; Palazón et al., 2012).”
Lactate metabolism in human health and disease
Li, X., Yang, Y., Zhang, B., Lin, X., Fu, X., An, Y., Zou, Y., Wang, J.-X., Wang, Z., & Yu, T. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01151-3 · Cited by 1,454
Foxp3 Reprograms T Cell Metabolism to Function in Low-Glucose, High-Lactate Environments
Angelin, A., Gil-de-Gómez, L., Dahiya, S., Jiao, J., Guo, L., Levine, M. H., Wang, Z., Quinn, W. J., Kopinski, P. K., Wang, L., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2016.12.018 · Cited by 1,246
“…that Tregs are unable to form L-lactate, and that there is an effective turnover of L-lactate to pyruvate in Tregs—we hypothesized that Tregs may be able to withstand the strong suppressive effects that L-lactate has on effector and cytotoxic T cells (Calcinotto et al., 2012; Fischer et al., 2007).”
BackgroundMetabolomics for Investigating Physiological and Pathophysiological Processes
Wishart, D. S. (2019) · Physiological Reviews · doi:10.1152/physrev.00035.2018 · Cited by 1,212
“Lactate is a known immunosuppressant (84), and its pH-lowering effect has been shown to induce a loss of T cell function in tumor-infiltrating lymphocytes (62, 84).”
Background
Metadata
- Authors
- Calcinotto, A., Filipazzi, P., Grioni, M., Iero, M., De Milito, A., Ricupito, A., Cova, A., Canese, R., Jachetti, E., Rossetti, M., Huber, V., Parmiani, G., Generoso, L., Santinami, M., Borghi, M., Fais, S., Bellone, M., & Rivoltini, L.
- Affiliations
- Vita-Salute San Raffaele University (IT)
- Authors' Affiliations: 1Cellular Immunology Unit, 2Immuno-biotherapy of Melanoma and Solid Tumors, San Raffaele Scientific Institute; 3Unit of Immunotherapy of Human Tumors, 4Melanoma and Sarcoma Unit, Fondazione IRCCS Istituto Nazionale dei Tumori; 5Università Vita-Salute San Raffaele, Milan; 6Department of Therapeutic Research and Medicines Evaluation, Unit of Antitumor Drugs, Istituto Superiore di Sanità, Rome, Italy; and 7Department of Oncology-Pathology, Cancer Center Karolinska, Karolinska Institute, Stockholm, Sweden
- ORCID
- Venue
- Cancer Research
- Published
- 2012-05-31
- Volume
- 72
- Issue
- 11
- Pages
- 2746-2756
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W2146037312
- Cited by
- 640
- References
- 48
- Citations by year
- 2026: 46 · 2025: 48 · 2024: 60 · 2023: 60 · 2022: 77 · 2021: 57 · 2020: 72 · 2019: 64 · 2018: 38 · 2017: 39 · 2016: 25 · 2015: 16 · 2014: 22 · 2013: 12 · 2012: 4
- FWCI
- 7.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Associazione Italiana per la Ricerca sul Cancro
- Ministero dell'Università e della Ricerca
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- tumor acidosis, T cell anergy, tumor-infiltrating T cells, CD8+ T cells, proton pump inhibitors, cancer immunotherapy, adoptive T cell therapy, immune evasion, STAT5 signaling, ERK signaling, IL-2 receptor alpha, T cell receptor, lactic acid, pH buffering, B16-OVA melanoma
- MeSH terms
- Animals, Female, Humans, Hydrogen-Ion Concentration, Interleukin-2, Lymphocyte Activation, Mice, Inbred C57BL, Omeprazole, Immunotherapy, Adoptive, Lymphocytes, Tumor-Infiltrating, Clonal Anergy, Mice, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Modulation of Microenvironment Acidity Reverses Anergy in Human and Murine Tumor-Infiltrating T Lymphocytes. https://app.cochat.ai/papers/10.1158/0008-5472.can-11-1272
- The paper
- Calcinotto, A., Filipazzi, P., Grioni, M., Iero, M., De Milito, A., Ricupito, A., Cova, A., Canese, R., Jachetti, E., Rossetti, M., Huber, V., Parmiani, G., Generoso, L., Santinami, M., Borghi, M., Fais, S., Bellone, M., & Rivoltini, L. (2012). Modulation of Microenvironment Acidity Reverses Anergy in Human and Murine Tumor-Infiltrating T Lymphocytes. Cancer Research. https://doi.org/10.1158/0008-5472.can-11-1272
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.